Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients

Summary

Many patients with eczema (atopic dermatitis) have an inherent defect in their skin barrier as demonstrated by high water loss. In laboratory conditions, studies have shown that pioglitazone restores the skin barrier function in skin from eczema patients. The purpose of this study is to determine if taking pioglitazone improves the skin barrier function in people with eczema.

Timeline

Start

2013-03

Primary completion

2014-01

Completion

2014-06

Drugs

Indications